ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |